| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2013 | S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors | RAY-HWANG YUAN ; Chang K.-T.; Chen Y.-L.; Hsu H.-C.; PO-HUANG LEE ; Lai P.-L.; YUNG-MING JENG | PLoS ONE | 24 | 23 | |
| 2012 | S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas | JIA-HUEI TSAI ; Huang W.-C.; KUAN-TING KUO ; RAY-HWANG YUAN ; Chen Y.-L.; YUNG-MING JENG | Histopathology | 32 | 29 | |
| 2014 | SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma model | Tai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN ; Chen K.-F. | Molecular Cancer Therapeutics | 6 | 6 | |
| 2018 | Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma | Hu M.-H.; Huang T.-T.; Chao T.-I.; Chen L.-J.; Chen Y.-L.; Tsai M.-H.; Liu C.-Y.; JIA-HORNG KAO ; Chen K.-F. | Liver International | 6 | 6 | |
| 2014 | Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer | Wang C.-Y.; Chao T.-T.; Tai W.-T.; Chang F.-Y.; Su W.-P.; Chen Y.-L.; Chen P.-T.; Weng C.-Y.; ANG YUAN ; Shiau C.-W.; CHONG-JEN YU ; Chen K.-F. | Journal of Thoracic Oncology | 11 | 11 | |
| 2018 | Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection | Lin C.-W.; Chen Y.-S.; Lin C.-C.; PO-HUANG LEE ; Lo G.-H.; Hsu C.-C.; Hsieh P.-M.; Koh K.W.; Bair M.-J.; Dai C.-Y.; Huang J.-F.; Chuang W.-L.; Chen Y.-L.; Yu M.-L. | PLoS ONE | 17 | 15 | |
| 1999 | Simian virus 40 T antigen induces p53-independent apoptosis but does not suppress erbB2/neu gene expression in immortalized human epithelial cells | Wang C.-H.; Chen Y.-L.; Tsao Y.-P.; SHOW-LI CHEN | Cancer Letters | 4 | 4 | |
| 2012 | SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis | Chen H.-C.; YUNG-MING JENG ; RAY-HWANG YUAN ; Hsu H.-C.; Chen Y.-L. | Annals of Surgical Oncology | 140 | 131 | |
| 2016 | Sleep problems and internet addiction among children and adolescents: a longitudinal study | Chen Y.-L.; SUSAN SHUR-FEN GAU | Journal of Sleep Research | 127 | 105 | |
| 2014 | Small interfering RNA targeting nerve growth factor alleviates allergic airway hyperresponsiveness | Chen Y.-L.; Huang H.-Y.; Lee C.-C.; BOR-LUEN CHIANG | Molecular Therapy - Nucleic Acids | 23 | 22 | |
| 2014 | STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma | Tai W.-T.; Chu P.-Y.; Shiau C.-W.; Chen Y.-L.; Li Y.-S.; Hung M.-H.; Chen L.-J.; PEI-LUNG CHEN ; Su J.-C.; Lin P.-Y.; Yu H.-C.; Chen K.-F. | Clinical Cancer Research | 76 | 72 | |
| 2013 | The stem cell E3-ligase Lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing | Chen Y.-L.; RAY-HWANG YUAN ; Yang W.-C.; Hsu H.-C.; YUNG-MING JENG | Journal of Pathology | 26 | 26 | |
| 2020 | Suicidality in Children with Elevated Autistic Traits | Chen Y.-Y.; Chen Y.-L.; SUSAN SHUR-FEN GAU | Autism Research | 10 | 10 | |
| 2013 | Taiwan aneurysm registry: Multivariate analysis of two-month, one-year, and two-year outcomes after endovascular and microsurgical treatment of ruptured aneurysms | HON-MAN LIU ; Wong H.-F.; Lee K.-W.; YONG-KWANG TU ; Yeh Y.-S.; Chou C.-W.; Wang Y.-H.; Chen Y.-L.; Lo Y.-L.; Hsieh T.-C.; Wang Y.-C.; Lin T.-K.; DAR-MING LAI ; Chen W.-L.; Tseng H.-M.; Li C.-W. | Interventional Neuroradiology | 4 | 3 | |
| 2007 | Targeting neuropilin 1 as an antitumor strategy in lung cancer | Hong, T.-M.; Chen Y.-L.; Wu, Y.-Y.; ANG YUAN ; Chao, Y.-C.; Chung, Y.-C.; Wu, M.-H.; SHIH-CHIN YANG; SZU-HUA PAN ; JIN-YUAN SHIH ; Chan W.-K.; PAN-CHYR YANG | Clinical Cancer Research | 178 | 152 | |
| 2017 | Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma | Hu M.-H.; Chen L.-J.; Chen Y.-L.; Tsai M.-S.; Shiau C.-W.; Chao T.-I.; Liu C.-Y.; JIA-HORNG KAO ; Chen K.-F. | Oncotarget | 17 | 15 | |
| 2016 | Targeting TSLP With shRNA Alleviates Airway Inflammation and Decreases Epithelial CCL17 in a Murine Model of Asthma | Chen Y.-L.; BOR-LUEN CHIANG | Molecular Therapy - Nucleic Acids | 12 | 15 | |
| 2014 | TD-19, an erlotinib derivative, induces epidermal growth factor receptor wild-type nonsmall-cell lung cancer apoptosis through CIP2A-mediated pathway | Chao T.-T.; Wang C.-Y.; Lai C.-C.; Chen Y.-L.; Tsai Y.-T.; Chen P.-T.; Lin H.-I.; Huang Y.-C.T.; Shiau C.-W.; CHONG-JEN YU ; Chen K.-F. | Journal of Pharmacology and Experimental Therapeutics | 27 | 28 | |
| 2021 | TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1 | Shih C.-T.; Shiau C.-W.; Chen Y.-L.; Chen L.-J.; Chao T.-I.; Wang C.-Y.; CHAO YUAN HUANG ; Hung M.-H.; Chen K.-F. | Cancer Letters | 9 | 9 | |
| 2002 | Technical note SEMG-controlled telephone interface for people with disabilities | Chen Y.-L.; Lai J.-S.; JER-JUNN LUH ; Kuo T.-S. | Journal of Medical Engineering and Technology | 9 | 0 | |
